Lack of effect of methotrexate on the expression of constitutive hepatic cytochromes P450 in the male rat

References

• Aarbakke J., Slordal L. Effects of anticancer drugs on drug metabolism. Anticancer Drugs: Reactive Metabolism and Drug Interactions, (International Encyclopedia of Pharmacology and Therapeutics, Section 141), G. Powis. Pergamon, Oxford 1994; 427–438
   Google Scholar
• Balis F. M. Pharmacokinetic drug interactions of commonly used anticancer drugs. Clinical Pharmacokinetics 1986; 11: 223–235
   PubMed Web of Science ®Google Scholar
• Basu T. K., Williams D. C. Effects of methotrexate and phenobarbital on the hepatic microsomal drug-metabolizing enzymes in normal rat. Chemotherapy 1975; 21: 33–40
   PubMed Web of Science ®Google Scholar
• Black S. D., Coon M. J. P-450 cytochromes: structure and function. Advances in Enzymology 1987; 60: 35–87
   PubMedGoogle Scholar
• Chang T. K. H., Weber G. F., Crespi C. L., Waxman D. J. Differential activation of cyclophosphamide and ifosphamide by cytochrome-P-450-2B and cytochrome-P450-3A in human liver microsomes. Cancer Research 1993; 53: 5629–5637
   PubMed Web of Science ®Google Scholar
• Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analytical Biochemistry 1987; 162: 156–159
   PubMed Web of Science ®Google Scholar
• Clarke L., Waxman D. J. Oxidative metabolism of cyclophosphamide: identification of the hepatic monooxygenase catalysts of drug activation. Cancer Research 1989; 49: 2344–2350
   PubMed Web of Science ®Google Scholar
• Cooper K. O., Reik L. M., Jayyosi Z., Bandiera S., Kelley M., Ryan D. E., Daniel R., McCluskey S. A., Levin W., Thomas P. E. Regulation of 2 members of the steroid-inducible cytochrome P450 subfamily (3A) in rats. Archives of Biochemistry and Biophysics 1993; 301: 345–354
   PubMed Web of Science ®Google Scholar
• Correia M. A. Rat and human liver cytochromes P450. Substrate and inhibitor specificities and functional markers. Cytochrome P450: Structure, Mechanism, and Biochemistry, 2nd edn, P. R. Ortiz de Montellano. Plenum, New York 1995; 607–630
   Google Scholar
• de Bruijn E. A., Driessen O., Leeflang P., van denBosch N., van Strijen E., Slee P. H. T. J., Hermans J. Pharmacokinetic interactions of cyclophosphamide and 5-fluorouracil with methotrexate in an animal model. Cancer Treatment Reports 1986; 70: 1159–1165
   PubMedGoogle Scholar
• Donelli M. G., Franchi G., Rosso R. The effect of cytotoxic agents on drug metabolism. European Journal of Cancer 1970; 6: 125–126
   PubMed Web of Science ®Google Scholar
• Donelli M. G., Garattini S. Drug metabolism after repeated treatments with cytotoxic agents. European Journal of Cancer 1971; 7: 361–364
   PubMed Web of Science ®Google Scholar
• Drago J. R., Nesbitt J. A. The Nb transitional cell bladder carcinoma model: dose response to methotrexate and adriamycin. Anticancer Research 1986; 6: 1019–1020
   PubMed Web of Science ®Google Scholar
• El Dareer S. M., Tillery K. F., Hill D. L. Disposition of 5-methyltetrahydrohomofolate and methotrexate in rats. Cancer Treatment Reports 1981; 65: 101–106
   PubMedGoogle Scholar
• Gonzalez F. J., Song B. -J., Hardwick J. P. Pregnenolone 16α-carbonitrile-inducible P-450 gene family: gene conversion and differential regulation. Molecular and Cellular Biology 1986; 6: 2969–2976
   PubMed Web of Science ®Google Scholar
• Graham M. A., Riley R. J., Kerr D. J. Drug metabolism in carcinogenesis and cancer chemotherapy. Pharmacology and Therapeutics 1991; 51: 275–289
   PubMed Web of Science ®Google Scholar
• Guengerich F. P. Roles of cytochrome P-450 enzymes in chemical carcinogenesis and cancer chemotherapy. Cancer Research 1988; 48: 2946–2954
   PubMed Web of Science ®Google Scholar
• Guengerich F. P. Reactions and significance of cytochrome P-450 enzymes. Journal of Biological Chemistry 1991; 266: 10019–10022
   PubMed Web of Science ®Google Scholar
• Guengerich F. P., Dannan G. A., Wright S. T., Martin M. V., Kaminsky K. S. Purification and characterization of liver microsomal cytochromes P-450: electrophoretic, spectral, catalytic, and immunochemical properties and inducibility of eight isozymes isolated from rats treated with phenobarbital or β-naphthoflavone. Biochemistry 1982; 21: 6019–6030
   PubMed Web of Science ®Google Scholar
• Guitton J., Souillet G., Riviere J. L., Gerard F., Guilluy R., Brazier J. L. Action of methotrexate on cytochrome P-450 monooxygenases in rats. Study performed with [C-13]-aminopyrine micro breath test. European Journal of Drug Metabolism and Pharmacokinetics 1994; 19: 119–124
   PubMed Web of Science ®Google Scholar
• Imaoka S., Inoue K., Funae Y. Aminopyrine metabolism by multiple forms of cytochrome P-450 from rat liver microsomes: simultaneous quantitation of four aminopyrine metabolites by high-performance liquid chromatography. Archives of Biochemistry and Biophysics 1988; 265: 159–170
   PubMed Web of Science ®Google Scholar
• Ireland C. M., Pittman S. M. Tubulin alterations in taxol-induced apoptosis parallel those observed with other drugs. Biochemical Pharmacology 1995; 49: 1491–1499
   PubMed Web of Science ®Google Scholar
• Kirita S., Matsubara T. cDNA cloning and characterization of a novel member of steroid-induced cytochrome-P450 3A in rats. Archives of Biochemistry and Biophysics 1993; 307: 253–258
   PubMed Web of Science ®Google Scholar
• Kominami S. Substrate binding and the reduction of cytechrome P-450. Cytochrome P-450, 2nd edn, T. Omura, Y. Ishimura, Y. Fujii-Kuriyama. Kodansha/Weinheim: VCH, Tokyo 1993; 64–80
   Google Scholar
• Komori M., Oda Y. A major glucocorticoid-inducible P450 in rat liver is not P450 3A1. Journal of Biochemistry 1994; 116: 114–120
   PubMed Web of Science ®Google Scholar
• Kroes A. C. M., Lindemans J., Schoester M., Abels J. Enhanced therapeutic effect of methotrexate in experimental rat leukemia after inactivation of cobalamin (vitamin B12) by nitrous oxide. Cancer Chemotherapy and Pharmacology 1986; 17: 114–120
   PubMed Web of Science ®Google Scholar
• LeBlanc G. A., Sundseth S. S., Weber G. F., Waxman D. J. Platinum anticancer drugs modulate P-450 messenger RNA levels and differentially alter hepatic drug and steroid hormone metabolism in male and female rats. Cancer Research 1992; 52: 540–547
   PubMed Web of Science ®Google Scholar
• LeBlanc G. A., Waxman D. J. Feminization of rat hepatic P-450 expression by cisplatin. Evidence for perturbations in the hormonal regulation of steroid-metabolizing enzymes. Journal of Biological Chemistry 1988; 263: 15732–15739
   PubMed Web of Science ®Google Scholar
• LeBlanc G. A., Waxman D. J. Interaction of anticancer drugs with hepatic monooxygenase enzymes. Drug Metabolism Reviews 1989; 20: 395–439
   PubMed Web of Science ®Google Scholar
• LeBlanc G. A., Waxman D. J. Mechanisms of cyclophosphamide action on hepatic P-450 expression. Cancer Research 1990; 50: 5720–5726
   PubMed Web of Science ®Google Scholar
• Loadman P. M., Bibby M. C. Pharmacokinetic drug interactions with anticancer drugs. Clinical Pharmacokinetics 1994; 26: 486–500
   PubMed Web of Science ®Google Scholar
• Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the folin phenol reagent. Journal of Biological Chemistry 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Mazel P. Experiments illustrating drug metabolism in vitro. Fundamentals of Drug Metabolism and Drug Disposition, B. N. LaDu, H. G. Mandel, E. L. Way. Williams & Wilkins, Baltimore 1971; 546–560
   Google Scholar
• McCluskey S. A., Racz W. J., Marks G. S. Properties of 17- to 19-day-old chick embryo liver microsomes: induction of cytochrome P-450, effect of storage at low temperature, and resistance to lipid peroxidation. Journal of Pharmacological Methods 1986; 16: 111–123
   PubMedGoogle Scholar
• Nash T. The colorimetric estimation of formaldehyde by means of the Hantzsch reaction. Biochemical Journal 1953; 55: 416–421
   PubMed Web of Science ®Google Scholar
• Nelson D. R., Kamataki T., Waxman D. J., Guengerich F. P., Estabrook R. W., Feyereisen R., Gonzalez F. J., Coon M. J., Gunsalus I. C., Gotoh O., Okuda K., Nebert D. W. The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA and Cell Biology 1993; 12: 1–51
   PubMed Web of Science ®Google Scholar
• Omura T., Sato R. The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. Journal of Biological Chemistry 1964; 239: 2370–2378
   PubMed Web of Science ®Google Scholar
• Pratt W. B., Ruddon R. W., Ensminger W. D., Maybaum J. The Anticancer Drugs, 2nd edn. Oxford University Press, New York 1994
   Google Scholar
• Ram P. A., Waxman D. J. Hepatic P450 expression in hypothyroid rats: differential responsiveness of male-specific P450 form-2a (IIIA2), form-2c (IIC11), and RLM2 (IIA2) to thyroid hormone. Molecular Endocrinology 1991; 5: 13–20
   PubMedGoogle Scholar
• Ryan D. E., Levin W. Purification and characterization of hepatic microsomal cytochrome P-450. Pharmacology and Therapeutics 1990; 45: 153–239
   PubMed Web of Science ®Google Scholar
• Ryan D. E., Levin W. Age- and gender-related expression of rat liver cytochrome P450. Cytochrome P450 (Handbook of Experimental Pharmacology, vol. 105), J. B. Schenkman, H. Greim. Springer, Berlin 1993; 461–476
   Google Scholar
• Scheufler E., Zetler G., Iven H. Pharmacokinetics and organ distribution of methotrexate in the rat. Pharmacology 1981; 23: 75–81
   PubMed Web of Science ®Google Scholar
• Strobel H. W., Dignam J. D. Purification and properties of NADPH-cytochrome P-450 reductase. Methods in Enzymology 1978; 52: 89–96
   PubMedGoogle Scholar
• Stupans I., Richards D. A., McClure M. T. Effects of 5-fluorouracil treatment on rat liver microsomal enzymes. Xenobiotica 1995; 25: 1–8
   PubMed Web of Science ®Google Scholar
• Tarnowski G. S., Schmid F. A., Cappuccino J. G., Stock C. C. Chemotherapy studies in an animal tumor spectrum. II. Sensitivity of tumors to fourteen antitumor chemicals. Cancer Research 1966; 26: 181–206
   PubMed Web of Science ®Google Scholar
• Waxman D. J. Rat hepatic cytochrome P-450 isozyme 2c. Identification as a male-specific, developmentally induced steroid 16α-hydroxylase and comparison to a female-specific cytochrome P-450 isoenzyme. Journal of Biological Chemistry 1984; 259: 15481–15490
   PubMed Web of Science ®Google Scholar
• Waxman D. J. Interactions of hepatic cytochromes P-450 with steroid hormones. Regioselectivity and stereospecificity of steroid metabolism and hormonal regulation of rat P-450 enzyme expression. Biochemical Pharmacology 1988; 37: 71–84
   PubMed Web of Science ®Google Scholar
• Waxman D. J. Rat hepatic P450IIA and P450IIC subfamily expression using catalytic, immunochemical, and molecular probes. Methods in Enzymology 1991; 206: 249–267
   PubMed Web of Science ®Google Scholar
• Waxman D. J., Dannan G. A., Guengerich F. P. Regulation of rat hepatic cytochrome P-450: age-dependent expression, hormonal imprinting, and xenobiotic inducibility of sex-specific isoenzymes. Biochemistry 1985; 24: 4409–4417
   PubMed Web of Science ®Google Scholar
• Waxman D. J., Ko A., Walsh C. Regioselectivity and stereoselectivity of androgen hydroxylations catalyzed by cytochrome P-450 isozymes purified from phenobarbital-induced rat liver. Journal of Biological Chemistry 1983; 258: 11937–11947
   PubMed Web of Science ®Google Scholar
• Weber G. F., Waxman D. J. Activation of the anti-cancer drug ifosphamide by rat liver microsomal P450 enzymes. Biochemical Pharmacology 1993; 45: 1685–1694
   PubMed Web of Science ®Google Scholar
• Wood A. W., Ryan D. E., Thomas P. E., Levin W. Regio- and stereoselective metabolism of two C19 steroids by five highly purified and reconstituted rat hepatic cytochrome P-450 isozymes. Journal of Biological Chemistry 1983; 258: 8839–8847
   PubMed Web of Science ®Google Scholar
• Zhou X. -J., Zhou-Pan X. -R., Gauthier T., Placidi M., Maurel P., Rahmani R. Human liver microsomal cytochrome P450 3A isozymes mediated vindesine biotransformation: metabolic drug interactions. Biochemical Pharmacology 1993; 45: 853–861
   PubMed Web of Science ®Google Scholar